Nutraceuticals and Cardiovascular Disease, 1st ed. 2021 An Evidence-based Approach for Clinical Practice Contemporary Cardiology Series
Coordonnateurs : Cicero Arrigo F.G., Rizzo Manfredi
This book provides an evidence-based approach for the clinical use of nutraceuticals in the prevention and management of cardiovascular disease. It examines cardiovascular disease epidemiology, risk factors, and the role of dietary patterns. Clinical chapters discuss the use of nutraceuticals in the management of medical conditions such as dyslipidemia, hypertension, insulin resistance, and heart failure. Each chapter contains a short epidemiological background; a list of relevant active compounds and their efficacy, tolerability, and safety; and suggestions for prescribers. This book is a practical guide with the best clinical evidence supporting the use of nutraceuticals in cardiology.
Nutraceuticals and Cardiovascular Disease: An Evidence-based Approach for Clinical Practice is an essential resource for physicians, residents, fellows, and medical students in cardiology, clinical nutrition, dietetics, and internal medicine.
Chapter 1. Introduction to Cardiovascular Disease Epidemiology and Risk Factors.- Chapter 2. Definition of Nutraceuticals (Both Scientific and Legal).- Chapter 3. Evidence-based Approach to Nutraceuticals in Cardiovascular Medicine.- Chapter 4. Dietary Patterns and Cardiovascular Disease Risk: From Epidemiology to Intervention.- Chapter 5. Single Dietary Components and Cardiovascular Disease Risk: From Epidemiology to Intervention.- Chapter 6. Nutraceuticals for Dyslipidemia Management.- Chapter 7. Nutraceuticals for Hypertension Management.- Chapter 8. Nutraceuticals for Management of Insulin Resistance.- Chapter 9. Nutraceuticals Supporting Body Weight Loss.- Chapter 10. Nutraceuticals for Non-alcoholic Fatty Liver Disease Management.- Chapter 11. Nutraceuticals for Homocysteine Reduction.- Chapter 12. Nutraceuticals Supporting Cognitive Function in Mild Cognitive Impairment.- Chapter 13. Nutraceuticals Supporting Heart Function in Heart Failure.- Chapter 14. Nutraceuticals with Potential Adverse Cardiovascular Events or Pharmacological Interaction with Cardiometabolic Drugs.
Arrigo F.G. Cicero, MD, PhD
President of the Italian Nutraceutical Society (SINut) Associate Professor of Dietary Sciences
Dept. of Medical and Surgical Sciences Alma Mater Studiorum
University of Bologna
Italy
Prof. Manfredi Rizzo, MD, PhD
Associate Professor of Internal Medicine
Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (PROMISE)
School of Medicine
University of Palermo
Italy
Discusses the use of nutraceuticals for medical conditions such as dyslipidemia, hypertension, insulin resistance, and heart failure
Includes the best clinical evidence supporting the use of nutraceuticals in cardiology
Examines cardiovascular disease epidemiology, risk factors, and the role of dietary patterns
Provides an evidence-based approach for the clinical use of nutraceuticals in the prevention and management of cardiovascular disease
Date de parution : 04-2022
Ouvrage de 300 p.
15.5x23.5 cm
Date de parution : 04-2021
Ouvrage de 300 p.
15.5x23.5 cm
Thèmes de Nutraceuticals and Cardiovascular Disease :
Mots-clés :
Cardiovascular disease and nutraceuticals; Cardiovascular disease prevention; Dietary supplements and cardiovascular disease; Evidence-based medicine and nutraceuticals; Nutraceuticals and heart failure; Nutraceuticals for cardiovascular disease prevention; Nutraceuticals for dyslipidemia management; Nutraceuticals for hypertension management; Nutraceuticals for management of cardiovascular disease
